Market Research Logo

United Kingdom Cardiac Rhythm Management Devices Market Outlook to 2025

United Kingdom Cardiac Rhythm Management Devices Market Outlook to 2025

Summary

GlobalData’s new report, United Kingdom Cardiac Rhythm Management Devices Market Outlook to 2025, provides key market data on the United Kingdom Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Cardiac Rhythm Management Devices market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Cardiac Rhythm Management Devices market.
  • Key players covered include Medtronic plc, Abbott Laboratories, Boston Scientific Corp. and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Rhythm Management Devices Segmentation
2.3 Definitions of Markets Covered in the Report
3 Cardiac Rhythm Management Devices Market, United Kingdom
3.1 Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), 2015-2025
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), by Segment, 2015-2025
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), by Segment, 2015-2025
3.1.3 Pacemakers Market, United Kingdom, Revenue ($m), by Segment, 2015-2025
3.2 Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2015-2025
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), by Segment, 2015-2025
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), by Segment, 2015-2025
3.2.3 Pacemakers Market, United Kingdom, Volume (Units), by Segment, 2015-2025
3.3 Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($) , 2015-2025
3.4 Cardiac Rhythm Management Devices Market, United Kingdom, Distribution Share by Revenue ($m), 2017
3.5 Cardiac Rhythm Management Devices Market, United Kingdom, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United Kingdom, Cardiac Rhythm Management Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Boston Scientific Corp
4.3.1 Company Overview
4.4 Biotronik AG
4.4.1 Company Overview
5 Cardiac Rhythm Management Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Asset Transactions
6.1.1 MicroPort Scientific to Acquire Cardiac Rhythm Management Business Franchise from LivaNova for USD190 Million
6.2 Private Equity
6.2.1 MicroPort Scientific and Yunfeng Capital to Acquire Cardiac Rhythm Management Business from LivaNova
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jan 08, 2018: LivaNova Announces Matthew J. Dodds as Senior Vice President, Corporate Development
7.1.2 Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
7.1.3 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel
7.1.4 May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer
7.1.5 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation
7.2 Financial Announcements
7.2.1 Feb 28, 2018: LivaNova Announces Fourth Quarter and Full-Year 2017 Results
7.2.2 Nov 02, 2017: LivaNova Reports Third Quarter 2017 Results
7.2.3 Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results
7.2.4 May 03, 2017: LivaNova Reports First Quarter 2017 Results
7.2.5 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance
7.3 Other Significant Developments
7.3.1 Sep 14, 2017: LivaNova to Explore Strategic Options for Cardiac Rhythm Management Business Franchise
7.4 Strategy And Business Planning
7.4.1 Feb 07, 2018: Caisson Interventional Expanding in Maple Grove
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 2: Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 3: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 4: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 5: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 6: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 7: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, 2015-2020
Table 8: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, 2021-2025
Table 9: Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2015-2020
Table 10: Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2021-2025
Table 11: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), 2015-2020
Table 12: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), 2021-2025
Table 13: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), 2015-2020
Table 14: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), 2021-2025
Table 15: Pacemakers Market, United Kingdom, Volume (Units), 2015-2020
Table 16: Pacemakers Market, United Kingdom, Volume (Units), 2021-2025
Table 17: Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($), 2015-2020
Table 18: Cardiac Rhythm Management Devices Market, United Kingdom, Average Price ($), 2021-2025
Table 19: Cardiac Rhythm Management Devices Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2017
Table 20: Cardiac Rhythm Management Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2017
Table 21: Cardiac Rhythm Management Devices Market Pipeline Products
Table 22: MicroPort Scientific to Acquire Cardiac Rhythm Management Business Franchise from LivaNova for USD190 Million
Table 23: MicroPort Scientific and Yunfeng Capital to Acquire Cardiac Rhythm Management Business from LivaNova
Table 24: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country
1.2 List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 4: Pacemakers Market, United Kingdom, Revenue ($m), USD Constant, 2015-2025
Figure 5: Cardiac Rhythm Management Devices Market, United Kingdom, Volume (Units), 2015-2025
Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, United Kingdom, Volume (Units), 2015-2025
Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, United Kingdom, Volume (Units), 2015-2025
Figure 8: Pacemakers Market, United Kingdom, Volume (Units), 2015-2025
Figure 9: Cardiac Rhythm Management Devices Market, United Kingdom, Company Share (%) 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report